Rip2: a novel therapeutic target for bacteria-induced inflammation?
Jeyaseelan
Samithamby
S
D000818:Animals; D007113:Immunity, Innate; D008089:Listeria monocytogenes / Q000276:immunology; D008088:Listeriosis / Q000188:drug therapy / Q000276:immunology* / Q000503:physiopathology; D051379:Mice; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism*; D053475:Receptor-Interacting Protein Serine-Threonine Kinase 2; D053422:Receptor-Interacting Protein Serine-Threonine Kinases; D013601:T-Lymphocytes / Q000276:immunology*
D017346:Protein Serine-Threonine Kinases; D053475:Receptor-Interacting Protein Serine-Threonine Kinase 2; D053422:Receptor-Interacting Protein Serine-Threonine Kinases; C506255:Ripk2 protein, mouse